Lifecore Biomedical

1 serious warning sign in Lifecore Biomedical’s filings.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 7 Aug 2025, plus the 10-Q filed 5 Aug 2026 and 15 later 8-Ks.

• Weak checks on its own accounts

  Serious

  The company said its checks on its own accounts did not work at the end of its latest quarter. Mistakes could slip into the numbers.

  “Based upon such evaluation, our principal executive officer and principal financial officer concluded that, because the material weakness in our internal control over financial reporting described in our Transition Report on Form 10-KT for the transition period ended December 31, 2025 had not been fully remediated as of June 30, 2026, our disclosure controls and procedures were not effective as of June 30, 2026.”

  Show the full paragraph

  As required by Rule 13a-15(b) under the Exchange Act, we have evaluated, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Form 10-Q. Based upon such evaluation, our principal executive officer and principal financial officer concluded that, because the material weakness in our internal control over financial reporting described in our Transition Report on Form 10-KT for the transition period ended December 31, 2025 had not been fully remediated as of June 30, 2026, our disclosure controls and procedures were not effective as of June 30, 2026.

  From the 10-Q filed 5 August 2026, Part I, Item 4. Controls and Procedures. Read it in the filing

• Changed auditor

  Worth knowing

  The company changed its auditor (the firm that checks its books) in the last two years.

  “On August 12, 2025, the Audit Committee approved the dismissal of BDO USA, P.C. (“BDO”), the Company’s current independent registered public accounting firm, and BDO was dismissed on that date.”

  From an 8-K filed 18 August 2025: Change of auditor. Read it in the filing

• One big customer

  Worth knowing

  One customer brings in a big share of sales: 44% last year. Losing that customer would hurt.

  “Alcon has been and continues to be one of the Company's largest customers, comprising 44 % and 39 % of its revenues for the fiscal years ended May 25, 2025 and May 26, 2024, respectively.”

  From the 10-K filed 7 August 2025, Item 8. Financial Statements and Notes. Read it in the filing

• It carries a lot of debt: 102.1× its equity.
• Sales have shrunk: 4.3% a year.

Whether the price already reflects the risks is what the deep dive is for.